- Home
- ANTX vs HUCK Comparison
ANTX vs HUCK Comparison
Compare ANTX & HUCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.80
N/A
Current Price
$3.11
Company Overview
Basic Information| Metric | ANTX | HUCK |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 159.5M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ANTX | HUCK |
|---|---|---|
| Price | $4.80 | $3.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $9.00 | $4.17 |
| AVG Volume (30 Days) | 225.1K | ★ 682.2K |
| Earning Date | 11-11-2026 | 09-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | 31.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $318,857,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $1.00 | $3.09 |
| 52 Week High | $7.19 | $3.45 |
Technical Indicators
Market Signals| Indicator | ANTX | HUCK |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 13.56 |
| Support Level | $4.61 | N/A |
| Resistance Level | $5.21 | $3.45 |
| Average True Range (ATR) | 0.40 | 0.15 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 11.76 | 16.39 |
Price Performance
Historical Comparison ANTX
HUCK
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.